Mechanisms of COX-2 inhibitors a possible link to CV events?

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1056卷 / 1期

关键词：

Blood Flow; Medium Release; Organ Transplant; Prostacyclin; Vessel Diameter;

D O I：

10.2165/00128415-200510560-00009

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[41] Clinical data with COX-1 and COX-2 inhibitors: what possible alerts in pharmacovigilance?
Larousse, C
Veyrac, G
THERAPIE, 2000, 55 (01): : 21 - 28
[42] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
Debabrata Mukherjee
Eric J Topol
Arthritis Res Ther, 5
[43] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
Luo, C
He, ML
Bohlin, L
ACTA PHARMACOLOGICA SINICA, 2005, 26 (08) : 926 - 933
[44] COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors
Whittle, BJR
GUT, 2000, 47 (03) : 320 - 325
[45] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
Cheng Luo
Ming-liang He
Lars Bohlin
Acta Pharmacologica Sinica, 2005, 26 : 926 - 933
[46] Glycosylation of cyclooxygenase-2 (COX-2) influences effectiveness of COX-2 inhibitors
Graham, Kamara Whitney
Sevigny, Mary B.
Gabriel, Bianca S.
FASEB JOURNAL, 2009, 23
[47] Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events
Mukherjee, D
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) : 817 - 821
[48] COX-2 inhibitors and gastrointestinal toxicity
Bombardier, C
Laine, L
Reicin, A
Shapiro, D
Burgos-Vargas, R
Davis, B
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 164 (08) : 1200 - 1200
[49] COX-2 inhibitors off the hook?
Dorey, E
CHEMISTRY & INDUSTRY, 2005, (05) : 5 - 5
[50] COX-2 inhibitors with a methylsulfoxide pharmacophore
Chung, S
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (05) : 617 - 620

← 1 2 3 4 5 →